Advanced Search

Technical Analysis for EVFM - Evofem Biosciences, Inc.

Grade Last Price % Change Price Change
grade C 6.87 0.15% 0.01
EVFM closed up 14.52 percent on Wednesday, February 19, 2020, on 4.42 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Feb 28
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical EVFM trend table...
Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.15%
Expansion Breakout Bullish Swing Setup 0.15%
Expansion Pivot Buy Setup Bullish Swing Setup 0.15%
Pocket Pivot Bullish Swing Setup 0.15%
Volume Surge Other 0.15%
Wide Range Bar Range Expansion 0.15%
Stochastic Reached Overbought Strength 0.15%
Wide Bands Range Expansion 0.15%
Above Upper BB Strength 0.15%
Overbought Stochastic Strength 0.15%
Older EOD signals for EVFM ...
View Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
EVFM Chart by TradingView
Basic chart:

Profile

Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Pharmaceutical Obesity

Is EVFM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Feb 19 51 Stocks Moving In Wednesday's Mid-Day Session
Feb 16 3 Monster Growth Stocks That Can Charge Forward in 2020
Dec 22 Hedge Funds Have Never Been This Bullish On Evofem Biosciences, Inc. (EVFM)
Dec 18 FDA accepts Evofem's refiled Amphora application
Dec 18 U.S. FDA Acknowledges Receipt of Evofem Biosciences' New Drug Application Resubmission for Amphora® for the Prevention of Pregnancy
Dec 5 Evofem Biosciences (EVFM) Presents At Piper Jaffray Healthcare Conference - Slideshow
Dec 3 PDL BioPharma Congratulates Evofem Biosciences on Achieving Major Regulatory and Clinical Milestones with its Lead Product Candidate Amphora®
Dec 3 The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial
Dec 2 SKT, CLVS among premarket gainers
Dec 2 Benzinga Pro's Top 5 Stocks To Watch For Mon., Dec. 2, 2019: EVFM, AQMS, ROKU, TDOC, COUP
See more EVFM news...

Indicators

Indicator Value
52 Week High 7.5
52 Week Low 3.19
Average Volume 81,065
200-Day Moving Average 5.51
50-Day Moving Average 5.77
20-Day Moving Average 5.26
10-Day Moving Average 5.40
Average True Range 0.41
ADX 24.74
+DI 49.53
-DI 11.58
Chandelier Exit (Long, 3 ATRs ) 5.99
Chandelier Exit (Short, 3 ATRs ) 5.83
Upper Bollinger Band 6.20
Lower Bollinger Band 4.32
Percent B (%b) 1.35
BandWidth 35.86
MACD Line 0.07
MACD Signal Line -0.13
MACD Histogram 0.2013
Fundamentals Value
Market Cap 94.86 Million
Num Shares 13.8 Million
EPS -0.74
Price-to-Earnings (P/E) Ratio -9.27
Price-to-Sales 0.00
Price-to-Book 2.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.30
Resistance 3 (R3) 8.26 7.73 8.06
Resistance 2 (R2) 7.73 7.37 7.76 7.98
Resistance 1 (R1) 7.30 7.14 7.52 7.34 7.90
Pivot Point 6.77 6.77 6.88 6.80 6.77
Support 1 (S1) 6.34 6.41 6.56 6.38 5.82
Support 2 (S2) 5.81 6.18 5.84 5.74
Support 3 (S3) 5.38 5.81 5.66
Support 4 (S4) 5.42